BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19466518)

  • 1. Matrix metalloproteinase-1 and -2 levels are differently regulated in acute exacerbation of heart failure in patients with and without left ventricular systolic dysfunction.
    Naito Y; Tsujino T; Lee-Kawabata M; Matsumoto M; Ezumi A; Nakao S; Goda A; Ohyanagi M; Masuyama T
    Heart Vessels; 2009 May; 24(3):181-6. PubMed ID: 19466518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.
    Nishikawa N; Yamamoto K; Sakata Y; Mano T; Yoshida J; Miwa T; Takeda H; Hori M; Masuyama T
    Cardiovasc Res; 2003 Mar; 57(3):766-74. PubMed ID: 12618238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.
    López B; González A; Querejeta R; Larman M; Díez J
    J Am Coll Cardiol; 2006 Jul; 48(1):89-96. PubMed ID: 16814653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.
    Iwanaga Y; Nishi I; Furuichi S; Noguchi T; Sase K; Kihara Y; Goto Y; Nonogi H
    J Am Coll Cardiol; 2006 Feb; 47(4):742-8. PubMed ID: 16487838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.
    Kitzman DW; Little WC; Brubaker PH; Anderson RT; Hundley WG; Marburger CT; Brosnihan B; Morgan TM; Stewart KP
    JAMA; 2002 Nov; 288(17):2144-50. PubMed ID: 12413374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure.
    Bruch C; Gradaus R; Gunia S; Breithardt G; Wichter T
    J Am Soc Echocardiogr; 2003 Oct; 16(10):1031-6. PubMed ID: 14566295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure.
    Watanabe S; Shite J; Takaoka H; Shinke T; Imuro Y; Ozawa T; Otake H; Matsumoto D; Ogasawara D; Paredes OL; Yokoyama M
    Eur Heart J; 2006 Apr; 27(7):832-8. PubMed ID: 16464912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focale: study of systolic and diastolic heart failure in a French elderly population.
    Dubourg O; Gueret P; Beauchet A; Nisse-Durgeat S; Ducardonnet A
    Int J Cardiol; 2008 Feb; 124(2):188-92. PubMed ID: 17399824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.
    Troughton RW; Prior DL; Pereira JJ; Martin M; Fogarty A; Morehead A; Yandle TG; Richards AM; Starling RC; Young JB; Thomas JD; Klein AL
    J Am Coll Cardiol; 2004 Feb; 43(3):416-22. PubMed ID: 15013124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction.
    Yu CM; Lin H; Yang H; Kong SL; Zhang Q; Lee SW
    Circulation; 2002 Mar; 105(10):1195-201. PubMed ID: 11889013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
    Yan AT; Yan RT; Spinale FG; Afzal R; Gunasinghe HR; Arnold M; Demers C; McKelvie RS; Liu PP
    J Card Fail; 2006 Sep; 12(7):514-9. PubMed ID: 16952784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.
    Zile MR; Bennett TD; St John Sutton M; Cho YK; Adamson PB; Aaron MF; Aranda JM; Abraham WT; Smart FW; Stevenson LW; Kueffer FJ; Bourge RC
    Circulation; 2008 Sep; 118(14):1433-41. PubMed ID: 18794390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
    Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
    Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute electrocardiographic presentation in patients with diastolic vs systolic heart failure.
    Zareba KM; Shenkman HJ; Bisognano JD
    Congest Heart Fail; 2009; 15(4):165-9. PubMed ID: 19627289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
    Pan W; Yang D; Yu P; Yu H
    BMC Cardiovasc Disord; 2020 Apr; 20(1):208. PubMed ID: 32354356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial structure and function differ in systolic and diastolic heart failure.
    van Heerebeek L; Borbély A; Niessen HW; Bronzwaer JG; van der Velden J; Stienen GJ; Linke WA; Laarman GJ; Paulus WJ
    Circulation; 2006 Apr; 113(16):1966-73. PubMed ID: 16618817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure.
    Nakao S; Goda A; Yuba M; Otsuka M; Matsumoto M; Yoshida C; Ohyanagi M; Naito Y; Lee M; Tsujino T; Masuyama T
    Circ J; 2007 Sep; 71(9):1412-7. PubMed ID: 17721020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.